Sunday - November 15, 2026
GSK showcases progress in liver portfolio at AASLD 2026
November 05, 2026
LONDON, England, Nov. 5 [Category: BizPharmaceuticals] -- GSK (formerly GlaxoSmithKline), a biopharmaceutical company, issued the following news release:

* * *

GSK showcases progress in liver portfolio at AASLD 2026

*

* Hibsago (bepirovirsen) treatment for patients with chronic hepatitis B (CHB) reinforced by new long-term dataset

* Further Hibsago research on surface antigen (HBsAg) reduction, retreatment modelling and functional . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Click here for more information about our products